Septerna, Inc. (SEPN)
NASDAQ: SEPN · Real-Time Price · USD
23.30
-0.57 (-2.39%)
Mar 30, 2026, 4:00 PM EDT - Market closed
Septerna Revenue
In the year 2025, Septerna had annual revenue of $45.95M with 4,174.51% growth. Septerna had revenue of $24.12M in the quarter ending December 31, 2025, with 11,276.42% growth.
Revenue (ttm)
$45.95M
Revenue Growth
+4,174.51%
P/S Ratio
22.77
Revenue / Employee
$353,469
Employees
130
Market Cap
1.05B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 45.95M | 44.88M | 4,174.51% |
| Dec 31, 2024 | 1.08M | 924.00K | 611.92% |
| Dec 31, 2023 | 151.00K | - | - |
| Dec 31, 2022 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionSEPN News
- 21 days ago - Septerna Highlights Pipeline Progress and Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 4 weeks ago - Septerna Announces Positive Phase 1 Data for SEP-631, an Oral MRGPRX2 NAM for the Treatment of Mast Cell-Driven Diseases, and Outlines Initial Phase 2 Development Strategy - GlobeNewsWire
- 4 weeks ago - Septerna to Present at TD Cowen 46th Annual Health Care Conference - GlobeNewsWire
- 6 weeks ago - Septerna Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - Septerna to Present Data from Phase 1 Clinical Trial of SEP-631 for the Treatment of Mast Cell-Driven Diseases at 2026 AAAAI Annual Meeting - GlobeNewsWire
- 2 months ago - Septerna Expands Leadership with Appointment of Industry Veteran Mark A. Wilson as Chief Legal Officer - GlobeNewsWire
- 3 months ago - Septerna to Present at 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 4 months ago - Septerna to Participate in 8th Annual Evercore Healthcare Conference - GlobeNewsWire